Literature DB >> 6653902

Peripheral nerve abnormalities in the diabetic mutant mouse.

A K Sharma, P K Thomas, G Gabriel, C Stolinski, P Dockery, G W Hollins.   

Abstract

Observations were made on the genetically diabetic C57BL/Ks (db/db) mouse. Morphometric observations were performed on the tibial nerve at 6, 9, and 15 mo and compared with those from nondiabetic (m/m) controls. Myelinated fiber size was less in the diabetic animals at all stages and affected cross-sectional axon area and myelin thickness equally. Unmyelinated axons were unaffected. The index of circularity of myelinated axons did not differ between diabetic and control animals. No definite absolute reduction in fiber size occurred and degenerative changes, which were slight, were equally frequent in the diabetic and control nerves. Axonal glycogenosomes, polyglucosan particles, and Schwann cell/axon networks, and Schwann cell Reich granules increased with age in both groups, but only glycogenosomes were consistently more numerous in the diabetic animals. Counts of membrane associated particles in both P and E faces revealed that these were reduced in number in the diabetic animals in myelin and in axolemma of unmyelinated axons, but not in the axolemma of myelinated fibers. Growth in tibial length was also reduced in the diabetic animals and this suggested that the reduced fiber diameter probably represented a maturational deficit. The absence of a selective reduction in axonal size did not favor a primary axonopathy as the cause.

Entities:  

Mesh:

Year:  1983        PMID: 6653902     DOI: 10.2337/diab.32.12.1152

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Freeze-fracture observations on human peripheral nerve.

Authors:  G Gabriel; P K Thomas; R H King; C Stolinski; A S Breathnach
Journal:  J Anat       Date:  1986-06       Impact factor: 2.610

2.  Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat.

Authors:  D Walker; A Carrington; S A Cannan; D Sawicki; J Sredy; A J Boulton; R A Malik
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

3.  Diabetic autonomic neuropathy. The distribution of structural changes in sympathetic nerves of the BB rat.

Authors:  S Yagihashi; A A Sima
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

4.  Axonopathy and microangiopathy in chronic alloxan diabetes.

Authors:  H C Powell; R R Myers
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

5.  Peripheral nerve intramembranous particle density and distribution in chronic streptozotocin-induced diabetes in rats.

Authors:  G Gabriel; P K Thomas; R H King; C Stolinski; A S Breathnach
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.

Authors:  I Ahmed; E Adeghate; E Cummings; A K Sharma; J Singh
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

Review 7.  Criteria for creating and assessing mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; Stephen I Lentz; John L Roberts; Eva L Feldman
Journal:  Curr Drug Targets       Date:  2008-01       Impact factor: 3.465

8.  Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats.

Authors:  P K Thomas; D W Wright; E Tzebelikos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.